|
By LAURAN NEERGAARD : AP Medical Writer
Jun 4, 2003 : 2:22 am ET
WASHINGTON -- Federal health officials warned
users of the top-selling cholesterol medicine Lipitor to check if
they have a fake version, as investigators uncovered more than
30,000 additional bottles containing counterfeit pills.
The maker of real Lipitor, Pfizer Inc., filed
suit Tuesday to stop a pharmaceutical repackaging company and
distributor from selling any more fake pills. Repackager Med-Pro
Inc. and Albers Medical Distributors both denied involvement in the
counterfeiting.
There are potentially significant health
risks because the fake pills will not lower cholesterol.
The Food and Drug Administration first
uncovered three batches of fake Lipitor almost two weeks ago, and
ordered Kansas City, Mo.-based Albers to recall 100,000 bottles. The
FDA announced Tuesday it had turned up three more batches containing
counterfeit pills.
To spot the fake version, look for the words
"Repackaged by MED-PRO Inc., Lexington, NE 68850" on 90-tablet
bottles that bear any of the following lot numbers:
--20842V, expiration 09-2004
--16092V, expiration 07-2004
--20722V, expiration 09-2004
--04132V, expiration 01-2004
--16942V, expiration 09-2004
--D270481, expiration not available.
All but that last batch are 10-milligram
tablets; the last one includes 20-milligram tablets.
Many patients taking Lipitor buy it in
smaller quantities dispensed in different bottles by their local
drugstore. Patients not sure if they have the counterfeit version
should call their pharmacist, who can check the pills' source, the
FDA advised.
"We want consumers, if there's any doubt at
all, to call their pharmacist," FDA Associate Commissioner John
Taylor said.
Pfizer said the counterfeit pills appear to
have a limited distribution. Millions of people take Lipitor, the
top-selling brand of cholesterol-lowering medicines known as
statins.
Pfizer said the fake pills bear a close
resemblance to real Lipitor, although they may be slightly thicker.
Consumers have reported that the fake pills dissolve faster and have
a slightly bitter taste. A handful of consumer complaints about the
taste prompted the FDA's probe.
Drug manufacturers typically sell their
products to a wholesaler that in turn sends tablets either directly
to pharmacies, or to a distributor and repackager before they arrive
at drugstores.
Pfizer sued Med-Pro and Albers on Tuesday,
saying it has no relationship with either of the companies so far
identified as handling the fake pills. The company said most Lipitor
arrives at pharmacies without such middlemen.
"We're suing to get the product off the
market and to identify the source," Pfizer spokeswoman Vanessa
McGowan said.
Med-Pro and Albers denied involvement.
"Med-Pro acted at all times in good faith and
was never knowingly involved in counterfeit Lipitor," company
attorney J.R. Hobbs said.
Albers attorney Kathy Dean said the fake
pills never came to the distributor's warehouse but were directly
shipped from Med-Pro to a small number of wholesalers.
"We are cooperating fully with the FDA and
are willing to work with Pfizer to identify the true source of the
counterfeit product," she said.
More counterfeit medicine is turning up in
the United States. In the last year, the FDA has investigated more
than half a dozen cases. Just last month, three men were charged in
Miami with a counterfeiting scheme that sold bacteria-tainted water
in the guise of the anti-anemia medicine Procrit.
|